Loor F - Search Results

1

Aureobasidins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC-transporter.

Tiberghien F, Kurome T, Takesako K, Didier A, Wenandy T, Loor F. Tiberghien F, et al. Among authors: loor f. J Med Chem. 2000 Jun 29;43(13):2547-56. doi: 10.1021/jm990955w. J Med Chem. 2000. PMID: 10891114

2

Cyclosporins: structure-activity relationships for the inhibition of the human MDR1 P-glycoprotein ABC transporter.

Loor F, Tiberghien F, Wenandy T, Didier A, Traber R. Loor F, et al. J Med Chem. 2002 Oct 10;45(21):4598-612. doi: 10.1021/jm0109863. J Med Chem. 2002. PMID: 12361387

3

Cyclosporins: structure-activity relationships for the inhibition of the human FPR1 formylpeptide receptor.

Loor F, Tiberghien F, Wenandy T, Didier A, Traber R. Loor F, et al. J Med Chem. 2002 Oct 10;45(21):4613-28. doi: 10.1021/jm010987v. J Med Chem. 2002. PMID: 12361388

4

Detection of P-glycoprotein expression by tumoral cells with NBDL-CsA, a fluorescent derivative of cyclosporin A.

Didier A, Tiberghien F, Wenger R, Loor F. Didier A, et al. Among authors: loor f. Anticancer Drugs. 1996 May;7(3):257-65. doi: 10.1097/00001813-199605000-00004. Anticancer Drugs. 1996. PMID: 8791998

5

Ranking of P-glycoprotein substrates and inhibitors by a calcein-AM fluorometry screening assay.

Tiberghien F, Loor F. Tiberghien F, et al. Among authors: loor f. Anticancer Drugs. 1996 Jul;7(5):568-78. doi: 10.1097/00001813-199607000-00012. Anticancer Drugs. 1996. PMID: 8862725

6

The abamectin derivative ivermectin is a potent P-glycoprotein inhibitor.

Didier A, Loor F. Didier A, et al. Among authors: loor f. Anticancer Drugs. 1996 Sep;7(7):745-51. doi: 10.1097/00001813-199609000-00005. Anticancer Drugs. 1996. PMID: 8949985

7

The potent immunosuppressive cyclosporin FR901459 inhibits the human P-glycoprotein and formyl peptide receptor functions.

Tiberghien F, Wenandy T, Loor F. Tiberghien F, et al. Among authors: loor f. J Antibiot (Tokyo). 2000 May;53(5):509-15. doi: 10.7164/antibiotics.53.509. J Antibiot (Tokyo). 2000. PMID: 10908115 Free article.

8

Decreased biotolerability for ivermectin and cyclosporin A in mice exposed to potent P-glycoprotein inhibitors.

Didier AD, Loor F. Didier AD, et al. Among authors: loor f. Int J Cancer. 1995 Oct 9;63(2):263-7. doi: 10.1002/ijc.2910630220. Int J Cancer. 1995. PMID: 7591215

9

Decreased uptake of cyclosporin A by P-glycoprotein (Pgp) expressing CEM leukemic cells and restoration of normal retention by Pgp blockers.

Didier A, Wenger J, Loor F. Didier A, et al. Among authors: loor f. Anticancer Drugs. 1995 Oct;6(5):669-80. doi: 10.1097/00001813-199510000-00006. Anticancer Drugs. 1995. PMID: 8845477

10

Expression of P-glycoprotein on normal lymphocytes: enhancement of the doxorubicin-sensitivity of concanavalin A-responding mouse spleen cells by P-glycoprotein blockers.

Pourtier-Manzanedo A, Didier A, Loor F. Pourtier-Manzanedo A, et al. Among authors: loor f. Oncol Res. 1992;4(11-12):473-80. Oncol Res. 1992. PMID: 1363723

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

126 results

Search Page

Filters